Cargando…
Type 1 Diabetic Neuropathy and C-peptide
The most common microvascular diabetic complication, diabetic peripheral polyneuropathy (DPN), affects type 1 diabetic patients more often and more severely. In recent decades, it has become increasingly clear that perpetuating pathogenetic mechanisms, molecular, functional, and structural changes a...
Autores principales: | Sima, Anders A. F., Zhang, Weixian, Grunberger, George |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2478622/ https://www.ncbi.nlm.nih.gov/pubmed/15198372 http://dx.doi.org/10.1080/15438600490424541 |
Ejemplares similares
-
C-Peptide Prevents Hippocampal Apoptosis in Type 1 Diabetes
por: Li, Zhen-guo, et al.
Publicado: (2002) -
The C-peptide Signaling
por: Grunberger, George, et al.
Publicado: (2004) -
The Effects of C-peptide on Type 1 Diabetic Polyneuropathies and Encephalopathy
in the BB/Wor-rat
por: Sima, Anders A. F., et al.
Publicado: (2008) -
C-peptide and Retinal Microangiopathy in Diabetes
por: Chakrabarti, Subrata, et al.
Publicado: (2004) -
Proinsulin C-peptide - A Consensus Statement
por: Sima, Anders A. F., et al.
Publicado: (2001)